...
机译:结肠直肠癌肝转移患者组合肝切除和射频消融:患有大量肿瘤的患者的可行选择
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Univ Athens Laiko Gen Hosp Med Sch Dept Propedeut Surg 2 Athens Greece;
Univ Athens Laiko Gen Hosp Med Sch Dept Propedeut Surg 2 Athens Greece;
Univ Athens Laiko Gen Hosp Med Sch Dept Propedeut Surg 2 Athens Greece;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Kumamoto Univ Grad Sch Life Sci Dept Gastroenterol Surg Kumamoto Japan;
Kumamoto Univ Grad Sch Life Sci Dept Gastroenterol Surg Kumamoto Japan;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Kumamoto Univ Grad Sch Life Sci Dept Gastroenterol Surg Kumamoto Japan;
Johns Hopkins Univ Sch Med Dept Surg Baltimore MD 21287 USA;
Colorectal cancer liver metastasis; hepatic resection; radio-frequency ablation;
机译:结肠直肠癌肝转移患者组合肝切除和射频消融:患有大量肿瘤的患者的可行选择
机译:孤立性结直肠肝转移患者的肝切除和射频消融的临床结局。
机译:进行肝切除以结直肠肝转移的患者中的KRAS突变:癌症生物学的生物标志物还是患者选择的副产物?
机译:切除或局部消融结直肠癌转移到肝脏 - PRO和CON
机译:转移相关基因的遗传变异和蛋白质表达是乳腺癌患者肿瘤侵袭性,复发和生存的标志。
机译:肝切除结直肠癌肝转移患者的KRAS突变:癌症生物学的生物标志物还是患者选择的副产物?
机译:结肠直肠癌肝转移患者的肝切除和射频消融:患有大量肿瘤的患者的可行选择